Musk’s Brain Implant Firm: FDA Reviewers Fired Amidst Controversy
Over the weekend, approximately 20 FDA employees in the office of neurological and physical medicine devices were terminated, impacting the agency’s review of medical device applications, including those from Neuralink. While the firings weren’t explicitly targeted at Neuralink reviewers, the loss of these employees, many of whom worked on Neuralink’s applications, will hinder the agency’s efficiency and potentially compromise safety. These probationary employees were dismissed despite positive performance reviews, raising concerns about the process and potential implications for Neuralink’s clinical trials. Outside experts express worry about the impact on the safety of trial participants.
John Q. Hosedrinker